Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wesolowski

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitorsXiulan Lai, Andrew Stiff, Megan Duggan, et al.
The Oncologist|May 6, 2014
Treatment-related mortality with everolimus in cancer patientsRobert Wesolowski, Mahmoud Abdel-Rasoul, Maryam Lustberg, et al.
Cancer Treatment Communications|April 28, 2015
Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicinGaurav Pahouja, Robert Wesolowski, Raquel Reinbolt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 26, 2023
Incidence, Clinicopathologic Features, HER2 Fluorescence In Situ Hybridization Profile, and Oncotype DX Results of Human Epidermal Growth Factor Receptor 2-Low Breast Cancers: Experience From a Single Academic CenterYan Hu, Dan Jones, Weiqiang Zhao, et al.
British Journal of Cancer|May 12, 2023
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumorsApostolia Maria Tsimberidou, Claire F Verschraegen, Robert Wesolowski, et al.
Frontiers in Oncology|August 7, 2025
Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancerVishnu Prasath, Briana To, Dionisia M Quiroga, et al.
Journal of Medical Case Reports|January 7, 2021
A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literatureSandipkumar H Patel, Yoshihito David Saito, Zaibo Li, et al.
Molecular and Cellular Endocrinology|January 11, 2015
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancerDrew R Oostra, Maryam B Lustberg, Raquel E Reinbolt, et al.
Biology|February 26, 2025
CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic ImplicationsSayan Mullick Chowdhury, Feng Hong, Christian Rolfo, et al.
Breast Cancer : Basic and Clinical Research|September 6, 2021
Tumor lysis Syndrome in a Patient with Metastatic Breast Cancer Treated with AlpelisibCaitlin Handy, Robert Wesolowski, Michelle Gillespie, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitorsXiulan Lai, Andrew Stiff, Megan Duggan, et al.
The Oncologist|May 6, 2014
Treatment-related mortality with everolimus in cancer patientsRobert Wesolowski, Mahmoud Abdel-Rasoul, Maryam Lustberg, et al.
Cancer Treatment Communications|April 28, 2015
Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicinGaurav Pahouja, Robert Wesolowski, Raquel Reinbolt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 26, 2023
Incidence, Clinicopathologic Features, HER2 Fluorescence In Situ Hybridization Profile, and Oncotype DX Results of Human Epidermal Growth Factor Receptor 2-Low Breast Cancers: Experience From a Single Academic CenterYan Hu, Dan Jones, Weiqiang Zhao, et al.
British Journal of Cancer|May 12, 2023
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumorsApostolia Maria Tsimberidou, Claire F Verschraegen, Robert Wesolowski, et al.
Frontiers in Oncology|August 7, 2025
Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancerVishnu Prasath, Briana To, Dionisia M Quiroga, et al.
Journal of Medical Case Reports|January 7, 2021
A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literatureSandipkumar H Patel, Yoshihito David Saito, Zaibo Li, et al.
Molecular and Cellular Endocrinology|January 11, 2015
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancerDrew R Oostra, Maryam B Lustberg, Raquel E Reinbolt, et al.
Biology|February 26, 2025
CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic ImplicationsSayan Mullick Chowdhury, Feng Hong, Christian Rolfo, et al.
Breast Cancer : Basic and Clinical Research|September 6, 2021
Tumor lysis Syndrome in a Patient with Metastatic Breast Cancer Treated with AlpelisibCaitlin Handy, Robert Wesolowski, Michelle Gillespie, et al.
Pageof 14